(VIANEWS) – NEXTENSA (NEXTA.BR), SPBK 1 NORDMØRE (SNOR.OL), AXA (CS.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. NEXTENSA (NEXTA.BR)
105.49% Payout Ratio
Nextensa is a mixed-use real estate investor and developer. The company's investment portfolio is divided between the Grand Duchy of Luxembourg (43%), Belgium (42%) and Austria (15%); its total value as at 31/12/2023 was approximately € 1.3 billion. As a developer, Nextensa is primarily active in shaping large urban developments. At Tour & Taxis (development of over 350,000 sqm) in Brussels, Nextensa is building a mixed real estate portfolio consisting of a revaluation of iconic buildings and new constructions. In Luxembourg (Cloche d'Or), it is working in partnership on a major urban extension of more than 400,000 sqm consisting of offices, retail and residential buildings. The company is listed on Euronext Brussels and has a market capitalisation of € 488.6 M (value 31/12/2023).
Earnings Per Share
As for profitability, NEXTENSA has a trailing twelve months EPS of €2.46.
PE Ratio
NEXTENSA has a trailing twelve months price to earnings ratio of 18.07. Meaning, the purchaser of the share is investing €18.07 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.86%.
More news about NEXTENSA.
2. SPBK 1 NORDMØRE (SNOR.OL)
50.76% Payout Ratio
SpareBank 1 Nordmøre provides various banking services in Norway. The company provides business insurance products, including liability, work machine, condominium, car, bus, boat, cyber, crime, truck, property, commercial building, project, trailer, and transport insurance; personal insurance products, such as life, business, travel, and accidental insurance products; pension products; bank cards; payment and debt collection services; and mobile and online banking services. It also offers bank guarantees, operating credit products for agriculture, and factoring and leasing products and services, as well as savings and deposit accounts, refinancing, and mortgage services. The company was founded in 1835 and is based in Kristiansund, Norway. SpareBank 1 Nordmøre operates as a subsidiary of SpareBank 1 Gruppen AS.
Earnings Per Share
As for profitability, SPBK 1 NORDMØRE has a trailing twelve months EPS of kr13.79.
PE Ratio
SPBK 1 NORDMØRE has a trailing twelve months price to earnings ratio of 8.97. Meaning, the purchaser of the share is investing kr8.97 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.58%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 78.2% and 12.9%, respectively.
Moving Average
SPBK 1 NORDMØRE’s value is higher than its 50-day moving average of kr122.02 and above its 200-day moving average of kr122.91.
More news about SPBK 1 NORDMØRE.
3. AXA (CS.PA)
50.66% Payout Ratio
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through six segments: France; Europe; AXA XL; Asia, Africa & EME-LATAM; AXA Investment Managers; and Transversal & Other segments It offers life and savings insurance products, such as savings and retirement, other health, and personal protection products. The company also provides property and casualty insurance products, including car, home, and personal or professional liability to individual and business clients; international insurance for large corporate clients in Europe; and marine and aviation insurance services, as well as property and casualty reinsurance products. In addition, it offers asset management services in the areas of various asset classes, including equities, bonds, hedge funds, private equity, and real estate for the group's insurance companies and their clients, and retail and institutional clients. Further, the company provides motor, household, property and general liability, health, term life, whole life, universal life, endowment, deferred and immediate annuities, and other investment-based products for personal/individual and commercial/ group customers. AXA SA was founded in 1852 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, AXA has a trailing twelve months EPS of €2.82.
PE Ratio
AXA has a trailing twelve months price to earnings ratio of 10.99. Meaning, the purchaser of the share is investing €10.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.69%.
More news about AXA.
4. SARTORIUS STED BIO (DIM.PA)
42.86% Payout Ratio
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.15%.
More news about SARTORIUS STED BIO.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
Sales Growth
1’s sales growth is 1% for the ongoing quarter and 1% for the next.
More news about 1.
